Showing results (11-20 of 180) with videos related to
Sort By:
Pageof 18
Bone Marrow Transplantation|September 5, 2020
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Didier Blaise, et al.Ejhaem|January 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitorGaétan Basile, Jean Galtier, Titouan Cazaubiel, et al.British Journal of Haematology|May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapseLuc Heraudet, Jean Galtier, Simon Favre, et al.Bone Marrow Transplantation|May 10, 2023
Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMTFrédéric Baron, Annalisa Ruggeri, Christophe Peczynski, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.Blood Advances|April 10, 2024
Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMTArnon Nagler, Myriam Labopin, Johanna Tischer, et al.Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.American Journal of Hematology|September 16, 2018
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMTMaximilian Christopeit, Myriam Labopin, Norbert-Claude Gorin, et al.Bone Marrow Transplantation|January 9, 2023
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Micha Srour, Tamim Alsuliman, Julien Labreuche, et al.American Journal of Hematology|April 4, 2017
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMTJonathan Canaani, Myriam Labopin, Gerard Socié, et al.Pageof 18